58
Views
0
CrossRef citations to date
0
Altmetric
Article

Extra-long Projections of the Cell Surface in Nonspecial-type Ductal Carcinoma with Vascular Invasion under the Scanning Electron Microscope

, PhD, , PhD, , MD, , MD, , MD & , PhD
Pages 73-77 | Received 22 Oct 2009, Accepted 23 Nov 2009, Published online: 01 Mar 2010

REFERENCES

  • Mehta TS, Raza S. Power Doppler sonography of breast cancer: does vascularity correlate with node status or lymphatic vascular invasion? Am J Roentgenol. 1999;173:303–307.
  • Pinder SE, Ellis IO, Galea M, O'Rourke S, Blamey RW, Elston CW. Pathological prognostic factors in breast cancer, III: vascular invasion—relationship with recurrence and survival in a large study with long-term follow-up. Histopathology. 1994;24:41–47.
  • Azmy IAF, Balasubramanian SP, Wilson AG, et al. Role of tumour necrosis factor gene polymorphisms (−308 and −238) in breast cancer susceptibility and severity. Breast Cancer Res. 2004;6:R395–R400.
  • Ghilard G, Blondi ML, Caccini F, de Monti M, Guagnellini E, Scorza R. Vascular invasion in human breast cancer is correlated to T→786 polymorphism of NOS3 gene. Nitric Oxide. 2003;9:118–122.
  • Hahnel R, Harvey J, Robbins P, Sterrett G. Cathepsin-D in human breast cancer: correlation with vascular invasion and other clinical and histopathological characteristics. Anticancer Res. 1993;13:2131–2135.
  • Van den Eynden G, Van der Auera I, Van Laere SJ, et al. Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study. Br J Cancer. 2006;94:1643–1649.
  • Westened PJ, Meurs GJG, Damhuis RAM. Tumor size and vascular invasion predict distant metastasis in stage I breast cancer: grade distinguishes early and late metastasis. J Clin Pathol. 2005;58:196–201.
  • Colleoni M, Rotmensz N, Maisonneuve P, et al. Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer. Ann Oncol. 2007;18:1632–1640.
  • Mathoulin-Portier MP, Meynard P, Charton-Bain MC, et al. Peritumoral vascular invasion in women with node- negative breast cancer, receiving no adjuvant therapy. Anticancer Res. 1999;19:843–847.
  • Dua RS, Gui GP, Isacke CM. Endothelial adhesion molecules in breast cancer invasion into the vascular and lymphatic systems. Eur J Surg Oncol. 2005;31:824–832.
  • Hope S. Rugo. Bevacizumab in the treatment of breast cancer: Rationale and current data. The Oncologist. 2004;9 (Suppl 1): 43–49.
  • Scott LJ. Bevacizumab: in first-line treatment of metastatic breast cancer. Drugs. 2007;67:1793–1799.
  • Voloudakis GE, Baltatzis GE, Stefanou D, Agnantis NJ, Voloudakis-Baltatzis I. Surface topography and ultrastructure correlation between human breast infiltrating ductal carcinoma of non special type and coexisting human breast infiltrating ductal carcinoma of non special type with in situ comedo carcinoma. BUON. 2003;8:151–156.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.